 |
| DNA Synthesizer Market |
The global DNA Synthesizer Market is estimated to be valued at US$ 4.30 Bn or Billion in 2023 and is expected to exhibit a CAGR of 20.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
DNA synthesizers are automated machines that are capable of producing short or
long oligonucleotides of DNA and RNA strands by solid-phase synthesis. They are
used for research and development activities in various fields such as
genomics, synthetic biology and others where large amounts of DNA are required.
They help save time and improve efficiency of DNA synthesis.
Market key trends:
Rising applications of DNA synthesizers in the healthcare and biotechnology
sector is a major trend driving the growth of this market. Healthcare and
biotechnology companies are increasingly using DNA synthesizers for various
applications such as DNA diagnostics, genetic engineering, DNA microarrays and
next generation sequencing. They are synthesizing oligonucleotides and primers
that are required for genomic sequencing, forensic analysis and DNA fingerprinting.
Recent advancements in DNA synthesis technologies have improved accuracy, yield
and throughput of DNA synthesizers. Continuous innovation fueld by R&D
investments from key players is also expected to boost the demand.
Segment Analysis
The global DNA synthesizer market is segmented based on product type,
application and end user. Based on product type, the market is segmented into
oligonucleotide synthesizer and DNA/RNA synthesizer. Among these, the DNA/RNA
synthesizer segment holds the largest market share and is expected to be the
fastest growing segment due to its wide applications in DNA library
construction, next generation sequencing, labeling of nucleotides and
polymerase chain reaction.
Based on application, the market is segmented into research applications and
diagnostic applications. The research applications segment holds the largest
market share owing to increasing adoption of DNA synthesizers in genomics
research and drug discovery activities. Within research applications, the DNA
library construction sub-segment accounts for the major share due to growing
demand for DNA sequencing.
Based on end user, the market is segmented into academic and research
institutes, diagnostic laboratories, pharmaceutical and biotechnology companies
and others. The academic and research institutes segment dominates the market
due to growing R&D spending on genomics and proteomics research.
Key Takeaways
The global DNA
Synthesizer Market Growth size
is expected to witness high growth, exhibiting a CAGR of 20.% over the forecast period 2023 to 2030, due to
increasing investments in genomics and drug discovery research.
By region, North America is expected to dominate the global DNA synthesizer
market during the forecast period. This is attributed to presence of key
players and growing biotech and pharmaceutical industries in the region. Europe
is expected to be the second largest market growing at a CAGR of 18% during the
forecast period due to government initiatives to promote genomics research in
the region. Asia Pacific region is projected to grow at the highest pace owing
to increasing healthcare expenditure, low-cost manufacturing facilities and
growing outsourcing of clinical research activities in countries like China and
India.
Key players operating in the DNA synthesizer market are Thermo Fisher
Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation (Integrated
DNA Technologies), GenScript Biotech Corporation, Eurofins Genomics, LGC
Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience
Corporation, Hamilton Company, Expedeon AG, New England Biolabs, Nippon
Genetics, LGC Biosearch Technologies. The major players are focusing on new
product launches, partnerships and acquisitions to gain competitive advantage
in the market.
Read More,
https://www.insightprobing.com/dna-synthesizer-market-trends-size-and-share-analysis/
0 Comments